Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/06/2003WO2003018028A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture
03/06/2003WO2003018027A1 Use of pregnane-diones or diols as neuropathic analgesic agents
03/06/2003WO2003018026A1 Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
03/06/2003WO2003018025A1 Method and composition for treatment of ocular hypertension and glaucoma
03/06/2003WO2003018024A1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
03/06/2003WO2003018023A1 Compositions and methods for targeting cerebral circulation and treatment of headache
03/06/2003WO2003018022A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
03/06/2003WO2003018021A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/06/2003WO2003018020A1 Jnk inhibitors
03/06/2003WO2003018019A2 New use of cyclic compounds
03/06/2003WO2003018018A2 Vinorelbine compositions and methods of use
03/06/2003WO2003018017A1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
03/06/2003WO2003018016A1 Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
03/06/2003WO2003018015A1 Pharmaceutical composition for preventing drug abuse by pproducing musous membrane irritation
03/06/2003WO2003018014A2 Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
03/06/2003WO2003018013A1 Stilbene derivative having cytochrome p450 1b1 inhibitory activity, pharmaceutically acceptable salt thereof, method for preparing the same, and composition including the same
03/06/2003WO2003018012A1 Preventive agent/remedial agent for constipation predominant ibs
03/06/2003WO2003018009A1 A combination of quetiapine and zolmitriptan
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2003018007A1 Antitumor agents and process for producing the same
03/06/2003WO2003018006A1 Porphyrin-zinc oxide complex and use of the same as photosensitive medicament which exitates photodynamic action by radiation and the use thereof in targeted therapy
03/06/2003WO2003018005A1 use of nefiracetam for treating neurodegeneration
03/06/2003WO2003018004A2 Analgetic pyrroline derivatives
03/06/2003WO2003018003A1 Ascorbic acid derivatives with essential amino acids, nonessential amino acids that do not occur in protein
03/06/2003WO2003018002A2 Cyclopropyl and cyclobutyl epothilone analogs
03/06/2003WO2003018001A1 Apolipo protein e secretion promoters
03/06/2003WO2003018000A1 Novel ascorbic acid compounds, methods of synthesis and application
03/06/2003WO2003017999A1 Treatment of scleroderma
03/06/2003WO2003017998A1 Platinum complexes and their use in cancer treatment
03/06/2003WO2003017997A1 The use of anthroquinones in the treatment of kidney disease
03/06/2003WO2003017996A1 Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
03/06/2003WO2003017995A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity
03/06/2003WO2003017994A1 Amidine derivatives for treating amyloidosis
03/06/2003WO2003017993A1 Photoreactive compounds and compositions
03/06/2003WO2003017992A2 Means for treatment of atherosclerosis
03/06/2003WO2003017991A2 Injection solution containing a dihydropyridin derivative
03/06/2003WO2003017990A2 Ophthalmic composition comprising an ascomycin
03/06/2003WO2003017989A1 Compositions and techniques for localized therapy of restenosis
03/06/2003WO2003017988A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups
03/06/2003WO2003017986A1 Compositions containing itraconazole and their preparation methods
03/06/2003WO2003017985A1 Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers
03/06/2003WO2003017984A1 A new extended release oral dosage form
03/06/2003WO2003017983A1 A new extended release oral dosage form
03/06/2003WO2003017982A1 A new extended release oral dosage form
03/06/2003WO2003017979A1 Method for the production of inhalation powders
03/06/2003WO2003017977A1 Anaesthetic formulations of propofol
03/06/2003WO2003017976A1 Synergistic mixed poloxamer systems for the solubilisation of drugs
03/06/2003WO2003017975A2 Method for producing solutions
03/06/2003WO2003017974A1 Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
03/06/2003WO2003017973A1 A method of treating benign gynaecological disorders and a drug delivery vehicle for use in such a method
03/06/2003WO2003017971A1 Drug delivery system
03/06/2003WO2003017960A1 Oral rinse for treatment or prevention of bacterial and fungal infection
03/06/2003WO2003017949A2 Novel synthetic ganglioside derivatives and compositions thereof
03/06/2003WO2003017946A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003WO2003017945A2 Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
03/06/2003WO2003017942A2 Ascorbic acid derivatives with amino acids
03/06/2003WO2003017941A2 Flexible applicator for applying oil-in-water emulsion with improved stability
03/06/2003WO2003017940A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
03/06/2003WO2003017939A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
03/06/2003WO2003017936A2 Use of dppiv inhibitors as diuretic and anti-hypertensive agents
03/06/2003WO2003017932A2 Compositions and methods for targeting cerebral circulation and treatment of headache
03/06/2003WO2003017931A2 Simmondsin processing methods and products
03/06/2003WO2003017929A2 Method for treating bronchial constriction and bronchospasm
03/06/2003WO2003017928A2 Method for treating bronchial constriction and bronchospam
03/06/2003WO2003017927A2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
03/06/2003WO2003017926A2 Treatment for lupus erythematosus
03/06/2003WO2003017925A2 Treatment of type i diabetes
03/06/2003WO2003017921A2 A method to improve complexation efficacy and produce high-energy cyclodextrin-complexes
03/06/2003WO2003017919A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
03/06/2003WO2003017824A2 Method and apparatus for acne treatment
03/06/2003WO2003017769A1 Antimicrobial agent
03/06/2003WO2003017765A1 Treatment for cystic fibrosis
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2003017763A1 Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cell
03/06/2003WO2003000240A3 Stable powder inhalation dosage formulation
03/06/2003WO2003000190A3 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
03/06/2003WO2002102382A9 A PROCESS FOR PREPARING PAROXETINE HCl WHICH LIMITS FORMATION OF PINK COLORED COMPOUNDS
03/06/2003WO2002102381A9 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002098901A3 Peptide deformylase inhibitors
03/06/2003WO2002094830A3 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
03/06/2003WO2002094219A3 Delivery of erectile dysfunction drugs through an inhalation route
03/06/2003WO2002094218A3 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
03/06/2003WO2002092122A3 Use of osteopontin for the treatment and/or prevention of neurologic diseases
03/06/2003WO2002089794A8 Method for treating neuropathic pain and pharmaceutical preparation therefor
03/06/2003WO2002089780A3 Antiviral compounds
03/06/2003WO2002089734A3 Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002085447A3 Microprojection array having a beneficial agent containing coating
03/06/2003WO2002085376A3 A method for decreasing superoxide anion production and for the treatment of diseases associated with oxidative stress
03/06/2003WO2002083129A3 Pharmaceutical composition comprising clavulanic acid
03/06/2003WO2002083066A3 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
03/06/2003WO2002074249A3 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
03/06/2003WO2002074200B1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin
03/06/2003WO2002072570A3 Non-imidazole compounds as histamine h3 antagonists
03/06/2003WO2002070470A3 Benzophenones as inhibitors of reverse transcriptase
03/06/2003WO2002069951A3 Composition containing a nefazonoid such as nefazodone and a serotonin-inhibitor such as fluoxetine
03/06/2003WO2002066516A3 Antibodies that bind both bcma and taci
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002064210A3 Combination therapy comprising anti-diabetic and anticonvulsant agents
1 ... 5542 5543 5544 5545 5546 5547 5548 5549 5550 5551 5552 5553 5554 5555 5556 5557 5558 5559 5560 5561 5562 ... 7860